최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of microbiology and biotechnology, v.19 no.6, 2009년, pp.616 - 621
Lee, Bo-Mi (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) , Lee, Jung-Hee (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) , Lee, Hye-Sung (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) , Bae, Eun-Ah (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University) , Huh, Chul-Sung (R & D Center, Korea Yakult Co., Ltd.) , Ahn, Young-Tae (R & D Center, Korea Yakult Co., Ltd.) , Kim, Dong-Hyun (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University)
To evaluate the effects of lactic acid bacteria (LAB) in inflammatory bowel diseases (IBD), we measured the inhibitory effect of several LAB isolated from intestinal microflora and commercial probiotics against the glycosaminoglycan (GAG) degradation by intestinal bacteria. Bifidobacterium longum HY...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Bai, A., N. Lu, Y. Guo, and X. Fan. 2008. Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig. Dis. Sci. 53: 421-428
Barthet, M., L. Dubucquoy, S. Garcia, S. Gasmi, P. Descreumaux, J. F. Colombel, J. C. Grimaud, J. Iovanna, and J. C. Dagorn. 2003. Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol. Clin. Biol. 27: 895-900
Belmiro, C. L., H. S. Souza, C. C. Elia, M. T. Castelo-Branco, F. R. Silva, R. L. Machado, and M. S. Pavao. 2005. Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease. Int. J .Colorectal Dis. 20: 295-304
Benno, P., C. E. Leijonmarck, U. Monsen, and A. Uribe. 1993. Functional alteration of the microflora in patients with ulcerative colitis. Scand. J. Gastroenterol. 28: 839-844
Berrebi, D., J. Languepin, L. Ferkdadji, A. Foussat, P. De Lagausie, R. Paris, et al. 2003. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 37: 300-308
Binder, V. 2004. Epidemiology of IBD during the twentieth century: An integrated view. Best Pract. Res. Clin. Gastroenterol. 18: 463-479
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
Campieri, M. and P. Gionchetti. 1999. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 116: 1246-1260
Chandran, P., S. Satthapom, A. Robins, and O. Eremin. 2003. Inflammatory bowel disease: Dysfunction of GALT and gut bacterial flora (II). Surgeon 1:125-136
Chung, K. T., G. E. Fulk, and M. W. Slein. 1975. Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J. Natl. Cancer Inst. 54: 1073-1078
Chung, Y. W., J. H. Choi, T. Y. Oh, C. S. Eun, and D. S. Han. 2008. Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in toll-like receptor 4 mutant mice. Clin. Exp. Immunol. 151: 182-189
Collins, M. P. and G. R. Gibson. 1999. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: s1052-s1057
Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewk, and K. H. Meyer zum Buschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin. Exp. Immunol. 102: 448-455
Fukuta, M., A. Chen, A. Klepper, S. Krishnareddy, A. S. Vamadevan, L. S. Thomas, et al. 2006. Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877
Ganguly, N. K., J. G. Kingham, B. Lloyd, R. S. Lloyd, C. P. Price, D. R. Triger, and R. Wright. 1978. Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet 1: 1073-1075
Gesner, B. M. and C. R. Jenkin. 1961. Production of heparinase by bacteroides. J. Bacteriol. 81: 595-604
Gilliland, S. E. 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 7: 175-188
Grabig, A., D. Paclik, C. Guzy, A. Dankof, D. C. Baumgart, J. Erckenbrecht, et al. 2006. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and tolllike receptor 4-dependent pathways. Infect. Immun. 74: 4075-4082
Han. W., A. Mercenier, A. Ait-Belgnaoui, S. Pavan, F. Lamine, I. I. van Swam, et al. 2006. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel Dis. 12: 1044-1052
Hill, M. J. and D. S. Drasar. 1975. The normal colonic bacterial flora. Gut 16: 318-323
Ingalls, R. R., H. Heine, E. Lien, A. Yoshimura, and D. Golenbock. 1999. Lipolysaccharide recognition, CD14, and lipolysaccharide receptors. Infect. Dis. Clin. N. Am. 13: 341-353
Keighley, M. R. and Y. Arabi. 1978. Influence of inflammatory bowel disease in intestinal microflora. Gut 19:1099-1104
Kruis, W. 2004. Antibiotics and probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20(Suppl. 4): 75-78
Lee, H. S., S. Y. Han, E. A. Bae, C. S. Huh, Y. T. Ahn, J. H. Kee, and D. H. Kim. 2008. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodiuminduced colitic mice. Int. Immunopharmacol. 8: 574-580
Mullane, K. M., R. Kraemer, and B. Smith. 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14: 157-167
Onderdonk, A. B., J. A. Aermos, and J. G. Barblett. 1979. The role of the intestinal microflora in experimental colitis. Am. J. Clin. Nutr. 30: 1819-1825
Peran, L., S. Sierra, M. Comalada, F. Lara-Villoslada, E. Bailon, A. Nieto, et al. 2007. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br. J. Nutr. 97:96-103
Perdigon, G.., W. E. B. de Jorrat, S. F. de Petrino, and M. Valerde de Budeguer. 1991. Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric. Immunol. 3: 93-102
Rhodes, J. M., R. Gallimore, and E. Elias. 1985. Fecal mucus degrading glycosidase in ulcerative colitis and Crohn's disease. Gut 26: 761-765
Sartor, R. B. 1994. Cytokines in intestinal inflammation:Pathophysiological and clinical consideration. Gastroenterology 106: 533-539
Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics and prebiotics. Gastroenterology 126: 1620-1633
Salyers, A. A., J. R. Vercellotti, S. E. H. West, and T. D. Wilkins. 1977. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microbiol. 34: 319-322
Shin, Y. W., E. A. Bae, S. S. Kim, Y. C. Lee, and D .H. Kim. 2005. Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int. Immunopharmacol. 5:1183-1191
Simon, G. L. and S. L. Gorbach. 1984. Intestinal flora in health and disease. Gastroenterology 86: 174-193
Singer, I. I., D. W. Kawka, S. Schloemann, T. Tessner, T. Riehl, and W. F. Stenson. 1998. Cyclooxygenase-2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306
Stiles, M. E. and W. H. Holzapfel. 1997. Lactic acid bacteria of foods and their current taxonomy. Int. J. Food Microbiol. 36: 1-29
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.